MIRA Pharmaceuticals, Inc.

8-K Delisting notice or listing-rule failure Jul 31, 2026 8-K Regulation FD disclosure Jul 10, 2026 8-K Regulation FD disclosure Jul 6, 2026 8-K Regulation FD disclosure Jun 25, 2026 8-K Regulation FD disclosure Jun 17, 2026 8-K Director or officer change Jun 8, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 4, 2026 8-K Entered a material agreement; Regulation FD disclosure May 27, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Regulation FD disclosure May 13, 2026 8-K Other events May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Other events Mar 23, 2026 8-K Other events Mar 3, 2026 8-K Other events Feb 2, 2026 8-K Director or officer change Dec 22, 2025 8-K Other events Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Other events Oct 23, 2025 8-K Other events Oct 16, 2025 8-K Other events Oct 15, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Other events Sep 30, 2025 8-K Other events Sep 22, 2025 8-K Other events Sep 15, 2025 8-K Director or officer change; Shareholder vote results Sep 11, 2025 8-K Other events Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Other events Aug 12, 2025 8-K Other events Jul 29, 2025 8-K Other events Jul 28, 2025 8-K Other events Jul 10, 2025 8-K Other events Jul 8, 2025 8-K Other events Jul 2, 2025 8-K Other events Jun 30, 2025 8-K Other events Jun 24, 2025 8-K Other events Jun 17, 2025 8-K Other events May 28, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change May 21, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Other events May 8, 2025